Glenmark Pharmaceuticals Limited, along with its subsidiaries, engages in the development, manufacturing, and marketing of pharmaceutical products across various regions including India, North America, Latin America, Europe, and globally. The company specializes in providing both branded and generic formulations in the fields of dermatology, respiratory, and oncology, as well as a range of active pharmaceutical ingredients. Its extensive product pipeline includes ISB 830 (telazorlimab), an OX40 antagonist monoclonal antibody currently undergoing Phase 2b clinical trials for the treatment of atopic dermatitis. Additionally, the company is conducting Phase 1/2 clinical trials for ISB 1302, a HER2 X CD3 beat bispecific antibody targeting metastatic HER2-positive breast cancer, and Phase 1 clinical trials for ISB 1342, a CD38 X CD3 beat bispecific antibody aimed at treating relapsed/refractory multiple myeloma. Glenmark Pharmaceuticals also has several pre-clinical stage products in its pipeline, such as ISB 880 for anti-inflammatory therapy, ISB 1908 and ISB 1909 T-cell engagers for oncology treatment, ISB 1442, an innate immune engager for oncology treatment, and GRC 39815, an inhibitor of the retinoid-related orphan receptor gamma for the treatment of chronic obstructive pulmonary disorder. Furthermore, the company offers Ryaltris nasal spray for allergic rhinitis. Established in 1977, Glenmark Pharmaceuticals is headquartered in Mumbai, India.
Navigation section
Glenmark Pharmaceuticals Limited
- 1,544.05 29.90(1.97%) 1,542.70 28.95(1.91%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 1,521.00 1,530.00 | 1,576.50 1576.75 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 771.00 (15-Feb-2024) 766.65 (15-Feb-2024) | 1,830.95 (15-Oct-2024) 1,830.05 (15-Oct-2024) |
- Open
- 1,535.00 1,540.00
- Previous Close
- 1,514.15 1,513.75
- Volume
- 17.76
- Total Traded value
- 275.50 (₹ Lakhs)
- Upper circuit
- 1,665.55 967.45
- Lower circuit
- 1,362.75 791.55
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 152 | 0 |
| Bid Price | Quantity |
|---|---|
| 1,542.65 | 152.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 152 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹435.71 Cr |
| PE Ratio (TTM): | 7.72 |
| PB Ratio: | 1.82 |
| Industry P/E: | 0.00 |
| Debt to Equity: | - |
| ROE: | 23.56 |
| EPS (TTM): | 199.94 |
| Book Value: | 643.02 |
| Face Value: | 1.00 |
Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 2,233.42 Cr | 2,144.38 Cr | 1,939.05 Cr | 2,161.47 Cr | 2,208.21 Cr |
| Profit | 302.35 Cr | 271.66 Cr | -137.47 Cr | 430.50 Cr | 423.15 Cr |
| Expense | 1,870.60 Cr | 1,770.07 Cr | 1,826.97 Cr | 1,824.58 Cr | 1,924.42 Cr |
| Comprehensive income | 298.81 Cr | 271.13 Cr | -140.18 Cr | 430.60 Cr | 418.37 Cr |
| EPS | 10.72 | 9.63 | -4.87 | 15.26 | 15.00 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Feb, 2000 Feb, 2000 | Pharmaceuticals Pharmaceuticals | GLENMARK GLENMARK |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Glenmark Pharmaceuticals Limited FAQ's
What is the range of today's stock performance for Glenmark Pharmaceuticals Limited?
Today's stock performance witnessed a fluctuation from a minimum of 1,521.00 on the NSE (National Stock Exchange) to a maximum of 1,576.50. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,530.00 to a high of 1,576.75.
What are the 52-week low and high values for Glenmark Pharmaceuticals Limited?
The stock's performance over the past 52 weeks reveals a low of 771.00 (occurred on 15-Feb-2024) and a high of 1,830.95 (achieved on 15-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 766.65 (on 15-Feb-2024), and the 52-week high is 1,830.05 (on 15-Oct-2024).
What was the opening and previous closing prices for Glenmark Pharmaceuticals Limited?
The stock's performance over the past 52 weeks reveals a low of 771.00 (occurred on 15-Feb-2024) and a high of 1,830.95 (achieved on 15-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 766.65 (on 15-Feb-2024), and the 52-week high is 1,830.05 (on 15-Oct-2024).
What is the total volume and traded value for Glenmark Pharmaceuticals Limited for the day?
The total volume is 18, and the total traded value is 275.50 (₹ Lakhs).
What are the upper and lower circuit limits for Glenmark Pharmaceuticals Limited?
The upper circuit limit is 1,665.55, and the lower circuit limit is 1,362.75.
What is the market cap and PE ratio for Glenmark Pharmaceuticals Limited?
The market cap is ₹435.71 Cr, and the PE ratio (TTM) is 0.00.
What is the PB ratio, industry P/E, and debt to equity ratio for Glenmark Pharmaceuticals Limited?
The PB ratio is 2.40, industry P/E is 0.00 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Glenmark Pharmaceuticals Limited?
ROE is 23.56, EPS is 199.94, book value is 643.02
What are the revenue and profit figures for the latest quarter and previous quarters for Glenmark Pharmaceuticals Limited?
In Sep 2023, Revenue is ₹22334160000.00, and Profit is ₹3023540000.00. In Jun 2023, Revenue is ₹21443840000.00, and Profit is ₹2716560000.00.
When was Glenmark Pharmaceuticals Limited listed, and what industry does it belong to?
The company, Glenmark Pharmaceuticals Limited, was listed in Feb 2000 and belongs to the Pharmaceuticals industry. Its NSE symbol is GLENMARK.
What is the current shareholding pattern of the Glenmark Pharmaceuticals Limited?
As of latest available update, promoters hold 46.65%, the public holds 53.35%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 96
